Literature DB >> 12451488

Cycloartane and oleanane saponins from egyptian astragalus spp. as modulators of lymphocyte proliferation.

Luisella Verotta1, Marco Guerrini, Nadia A El-Sebakhy, Aya M Assad, Soad M Toaima, Mohamed M Radwan, Ying-De Luo, John M Pezzuto.   

Abstract

From the roots of Astragalus kahiricus DC., three known saponins, namely, astraversianin VI, astraversianin X, astragaloside VIII, and a new saponin were isolated and identified by spectral data. The structure of the latter was elucidated by spectral means and assigned as cycloastragenol 3- O-[ beta- D-(2',3'-diacetyl, 4'- trans-2-butenoyl)-xylopyranosyl], 6- O- beta- D-xylopyranoside (kahiricoside I). From the aerial parts of A. hamosus L., the known compounds azukisaponin V and peregrinoside I were isolated. As judged by in vitro tests, the saponins isolated from Astragalus spp. endemic to Egypt were not cytotoxic against a variety of human cancer cells. However, dose-related modulation of lymphocyte proliferation was observed, and structure-activity relationships are described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451488     DOI: 10.1055/s-2002-35654

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  The Role of Saponins in the Treatment of Neuropathic Pain.

Authors:  Bei Tan; Xueqing Wu; Jie Yu; Zhong Chen
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

2.  Evaluation of Anti-inflammatory and Analgesic Activity of the Extract and Fractions of Astragalus hamosus in Animal Models.

Authors:  Asie Shojaii; Majid Motaghinejad; Sima Norouzi; Manijeh Motevalian
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Screening for Astragalus hamosus Triterpenoid Saponins Using HPTLC Methods: Prior Identification of Azukisaponin Isomers.

Authors:  Khouloud Nafti; Geraldine Giacinti; Sonia Marghali; Christine Delgado Raynaud
Journal:  Molecules       Date:  2022-08-23       Impact factor: 4.927

Review 4.  Cycloastragenol: An exciting novel candidate for age-associated diseases.

Authors:  Yongjie Yu; Limin Zhou; Yajun Yang; Yuyu Liu
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.